Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Luis E. Colunga Lozano"'
Autor:
Cristián Mansilla, Cristian A Herrera, Laura Boeira, Andrea Yearwood, Analia S Lopez, Luis E Colunga-Lozano, Eva Brocard, Tatiana Villacres, Marcela Vélez, Gabriel Di Paolantonio, Ludovic Reveiz
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263981 (2022)
IntroductionThe Coronavirus Disease 2019 (COVID19) pandemic has struck Latin America and the Caribbean (LAC) particularly hard. One of the crucial areas in the international community's response relates to accelerating research and knowledge sharing.
Externí odkaz:
https://doaj.org/article/bb38ab2e331745bcb39676540a958622
Autor:
Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, Maria T. DeSancho, David Diuguid, Daniel O. Griffin, Susan R. Kahn, Frederikus A. Klok, Alfred Ian Lee, Ignacio Neumann, Ashok Pai, Marc Righini, Kristen M. Sanfilippo, Deborah M. Siegal, Mike Skara, Deirdra R. Terrell, Kamshad Touri, Elie A. Akl, Reyad Al Jabiri, Yazan Al Jabiri, Angela M. Barbara, Antonio Bognanni, Mary Boulos, Romina Brignardello-Petersen, Rana Charide, Luis E. Colunga-Lozano, Karin Dearness, Andrea J. Darzi, Heba Hussein, Samer G. Karam, Razan Mansour, Gian Paolo Morgano, Rami Z. Morsi, Giovanna Muti-Schünemann, Menatalla K. Nadim, Binu A. Philip, Yuan Qiu, Yetiani Roldan Benitez, Adrienne Stevens, Karla Solo, Wojtek Wiercioch, Reem A. Mustafa, Holger J. Schünemann
Publikováno v:
Blood Advances, 6(17), 4915-4923. ELSEVIER
Background: COVID-19–related acute illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines from the American Society of Hematology (ASH) are intended to support patients, clinicians,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3763a0e1a403a0538fc55024b5fbb93
https://doi.org/10.1182/bloodadvances.2022007561
https://doi.org/10.1182/bloodadvances.2022007561
Autor:
Adam Cuker, Eric K. Tseng, Holger J. Schünemann, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, Maria T. DeSancho, David Diuguid, Daniel O. Griffin, Susan R. Kahn, Frederikus A. Klok, Alfred Ian Lee, Ignacio Neumann, Ashok Pai, Marc Righini, Kristen M. Sanfilippo, Deborah M. Siegal, Mike Skara, Deirdra R. Terrell, Kamshad Touri, Elie A. Akl, Reyad Al Jabiri, Yazan Al Jabiri, Mary Boulos, Romina Brignardello-Petersen, Rana Charide, Luis E. Colunga-Lozano, Karin Dearness, Andrea J. Darzi, Samer G. Karam, Gian Paolo Morgano, Rami Z. Morsi, Binu A. Philip, Yetiani Roldan Benitez, Adrienne Stevens, Karla Solo, Wojtek Wiercioch, Reem A. Mustafa, Robby Nieuwlaat
Publikováno v:
Blood Advances, 6(17), 4975-4982. ELSEVIER
Background: COVID-19–related critical illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0b7a34538891b5ed432fa86d9de962
https://hdl.handle.net/1887/3566924
https://hdl.handle.net/1887/3566924
Autor:
Caroline B. Terwee, Madeleine King, Manya Prasad, Vanessa Wong, Luis E. Colunga Lozano, Meha Bhatt, Michael Walsh, Tahira Devji, Anila Qasim, Gordon H. Guyatt, Ying Wang, Alonso Carrasco-Labra, Qiukui Hao, Maryam Ghadimi, Atefeh Noori, Yuting Wang, Mark Phillips, Berend Terluin, Toshi A. Furukawa, Yingqi Xiao
Publikováno v:
Wang, Y, Devji, T, Qasim, A, Hao, Q, Wong, V, Bhatt, M, Prasad, M, Wang, Y, Noori, A, Xiao, Y, Ghadimi, M, Lozano, L E C, Phillips, M R, Carrasco-Labra, A, King, M, Terluin, B, Terwee, C B, Walsh, M, Furukawa, T A & Guyatt, G H 2022, ' A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes ', Journal of Clinical Epidemiology, vol. 142, pp. 144-151 . https://doi.org/10.1016/j.jclinepi.2021.10.028
Objective : To systematically survey the literature addressing the reporting of studies estimating anchor-based minimal important differences (MIDs) and choice of optimal MIDs. Study design and Setting : We searched Medline, Embase and PsycINFO from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74c92bbf2569bd01a6d97f931818f48
https://research.vumc.nl/en/publications/7184ad8a-14ee-4138-90a9-e32d6475c64d
https://research.vumc.nl/en/publications/7184ad8a-14ee-4138-90a9-e32d6475c64d
Autor:
Luis E. Colunga Lozano, Gordon H. Guyatt, Maureen O. Meade, Erik Loewen Friesen, Farid Foroutan, Aman Sidhu
Publikováno v:
Systematic Reviews, Vol 8, Iss 1, Pp 1-5 (2019)
Systematic Reviews
Systematic Reviews
Background Upon surviving the first year post-lung transplantation, recipients can expect a median survival of 8 years. Within the first year, graft failure and multi-organ failure (possibly secondary to graft failure) are common causes of mortality.
Autor:
Paul E. Alexander, Sameer Sharif, Francois Lamontagne, Dipayan Chaudhuri, Waleed Alhazzani, Zhikang Ye, John Marshall, Manoj J. Mammen, Aram Karkar, Gianfranco Umberto Meduri, Stephen M. Pastores, Luis E. Colunga Lozano, Kiyoka Sasaki, Anders Perner, Marie Warrer Munch, Lawrence Mbuagbaw, Djillali Annane, Bram Rochwerg, Kimberly Lewis, Bin Du
Publikováno v:
Intensive Care Medicine
Intensive Care Medicine, Springer Verlag, 2021, 47 (5), pp.521-537. ⟨10.1007/s00134-021-06394-2⟩
Intensive Care Medicine, Springer Verlag, 2021, 47 (5), pp.521-537. ⟨10.1007/s00134-021-06394-2⟩
Purpose Corticosteroids are now recommended for patients with severe COVID-19 including those with COVID-related ARDS. This has generated renewed interest regarding whether corticosteroids should be used in non-COVID ARDS as well. The objective of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463414001d08ccb55808e6912ae178bc
https://hal.archives-ouvertes.fr/hal-03256433
https://hal.archives-ouvertes.fr/hal-03256433
Autor:
Yung Lee, Luis E. Colunga Lozano, Tahira Devji, Niveditha Devasenapathy, Michael Walsh, Ying Zhang, Xin Sun, Matthias Briel, Gordon H. Guyatt, Lehana Thabane, Arnav Agarwal, Joey S.W. Kwong, Yaping Chang, Neera Bhatnagar, Hannah Ewald, Stefan Schandelmaier
Objective The objective of the study was to systematically survey the methodological literature and collect suggested criteria for assessing the credibility of effect modification and associated rationales. Study Design and Setting We searched MEDLIN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465667815847379473b38a8421a4bb05
https://ruj.uj.edu.pl/xmlui/handle/item/257522
https://ruj.uj.edu.pl/xmlui/handle/item/257522
Publikováno v:
Critical Care Medicine. 49:101-101
INTRODUCTION: In December 2019, an outbreak of a new strain of coronavirus (Covid-19) was registered Currently, COVID-19 has affected 213 countries around the world, with approximately 6, 097,160 active cases, from which, 1% are serious or critical (
Autor:
Neera Bhatnagar, Malgorzata M Bala, Joey S.W. Kwong, Yung Lee, Matthias Briel, Gordon H. Guyatt, Ying Zhang, Luis E. Colunga Lozano, Xin Sun, Yaping Chang, Michael Walsh, Hannah Ewald, Stefan Schandelmaier, Arnav Agarwal, Tahira Devji, Niveditha Devasenapathy, Lehana Thabane
Publikováno v:
Journal of Clinical Epidemiology. 123:189
Autor:
Gerardo Amaya Tapia, Luis Blanco-Ornelas, Luis E. Colunga Lozano, Adrián Rojas Murguía, Hermes Rico, Julio C Mijangos-Méndez, Alejandra Sanchez Hernandez, Arturo Gómez, Óscar Radillo Mártinez, Victor Ramos-Martin, Miguel A Ibarra-Estrada, Adriana Rosas-Pérez, Carmen Román-Jiménez, Federico Corona-Jiménez, Quetzalcoatl Chavez Peña, Guadalupe Aguirre Avalos, José Arnulfo López Pulgarín
Publikováno v:
Critical Care Medicine. 48:270-270